Dr AS Goolam

Dad. Sometimes Urologic oncologist, Surgeon & patient advocate. #FOAMED #MedEd. RT ≠ endorsement

[USANZ @USANZUrology]

Congratulations to Associate Professor Matthew Roberts who has been selected to participate on the EAU Prostate Cancer Guidelines Panel. @mj_robbo will represent the high standards and reputation of our Members on a globally influential panel https://t.co/n06OICAuJH @Uroweb

[USANZ @USANZUrology]

In the lead-up to #UAA2022, today was day 2 of the Asian Urology Residents Course (AURC) where our enthusiastic delegates were treated to presentations by @AmerUrological faculty including @DrJohnDenstedt, @Scarps_kristen, @DrLAckerman, and @aseemrshukla.

[Laura Horodyski @lhorodyskimd]

Great discussion on the safety of ligating the left renal vein when resecting right RCC and IVC thrombus at ⁦@SES_AUA⁩ this morning! ⁦@miami_urology⁩

[UMiami Health System @UMiamiHealth]

@dipenjparekh, Chief Operating Officer at UHealth and Founding Director of the Desai Sethi Urology Institute, describes how the new #Urology Institute will advance life-saving therapies, educate the future physicians, and provide personalized #PatientCare.

[Dr AS Goolam @asgoolam]

#ProstateCancer
I found three to be an excellent resource for all interested in prostate cancer and clinical urology.
Superb work by @premrashid

Highly recommended.
@urologytraining

[Minhaj Siddiqui @MMSiddiquiMD]

My thoughts re: low-risk @NCCN guideline PCa AS change removing "preferred". Is removing preferred really going to change clinical practice? I doubt it. But is this a lost opportunity to improve practice paradigms? yes... See my thread below.

[Cleveland Clinic MD @CleClinicMD]

New study findings help clarify the role of neoadjuvant chemotherapy in the management of bladder cancer with variant histology: https://t.co/rZ2LziLKj8

[Dr AS Goolam @asgoolam]

Oh my!
This one is baffling….
#medtwitter #crazy

[giorgi khvadagiani @gkhvadagiani]

Ureteral stent inserted through cava and heart to lung artery. #urology #loveurology #itsnotsupposedtobethere

[Dr AS Goolam @asgoolam]

#EidAlAdha
Wishing all a safe and joyous Eid.

[PCFA @PCFA]

Meet Levina, our new Prostate Cancer Specialist Nurse in Nthrn SYD. We know now, more than ever, having access to support is important.
Levina joins our network of > 86 specialist nurses around the country – all motivated to make a difference. 🩺🏥
Welcome Levina
#PCFA #nurse

[UroToday.com @urotoday]

There is no role for radical cystectomy in cT0 after neoadjuvant chemotherapy. Presentation by @amassonlecomte @HopSaintLouis. #EAU21 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/vRPdUR3ooI @Uroweb

[Dr AS Goolam @asgoolam]

@mj_robbo
It’s a privilege to work alongside and learn from our future colleagues-in-training.

You bring with you a wealth of knowledge and experience. We learn just as much from you as you do from us.

Your trainees are fortunate to work with you!
@urologytraining

[Matt Roberts @mj_robbo]

Flashbacks to Neps 2019, such fond memories, left console was mine!

Still so appreciative of the excellent training 🙏🏻 @KhadraUrology @a1p4u @celivarol @asgoolam @matthewwinter01 @DrRaymondKo and support from @NBMLHD @device_robotics @ERUSrobotics

[Dr AS Goolam @asgoolam]

Excellent work!

Useful to help steer management and patient expectations.
It’s great to see data to back up contemporary practice.
@mj_robbo @GeoffCoughlin @johnyaxley @drlouiseemmett & team

#ProstateCancer @PCFA

[European Urology @EUplatinum]

External Validation and Addition of PSMA PET to the Most Frequently Used Nomograms for the Prediction of Pelvic Lymph-node Metastases: an International Multicenter Study
https://t.co/mDQ9POspXc
@robo_vis @IvoSchootsNL @hvdpoel

[Chris Barbieri @Chris_Barbieri1]

Excited for our most recent work published in JCI https://t.co/BFmpiqk0EZ, showing different modes of molecular and clinical progression in distinct molecular subtypes of prostate cancer.

A tweetorial thread --> 1/n

[Dr AS Goolam @asgoolam]

@USANZUrology
Excellent webinar on the difficult MRI prostate cases hosted by @JGrummet.

Great to hear from the assembled experts including @EmbertonMark @TarlintonLisa.

Increasing utility of PSMA PET earlier in the diagnostic and treatment pathway for prostate cancer.

[James C Lee @miR_JLEE]

The endocrine surgery glamazons at the #Racs21 dinner @NGVMelbourne @RACSurgeons @csl888 @DrAntG @JonathanSerpell

[Dr AS Goolam @asgoolam]

2/x
- there is much discussion regarding tours of mesh repair (splitting mesh vs. laying flat)
- we need a hernia repair registry to understand what works and what doesn’t
- the causes for orchalgia post hernia repair remain unclear

[Dr AS Goolam @asgoolam]

@RACSurgeons @USANZUrology #RACS21

GenSurg advice re: mesh and RARP

- Avoid intraperitoneal exposed mesh
- Mesh repair better performed by surgeons doing higher number of procedures
- No hard & fast rule about approach to repair (MIS vs. open)
- Don’t fix asymptomatic hernias

[Dr AS Goolam @asgoolam]

@USANZUrology #RACS21

Lymph node yield post mesh repair associated with lower lymph node yield.

Preoperative imaging may allude to which patients are likely to develop post-RARP hernia formation. Look for fat along the cord or fluid in the scrotum.